Management of chronic obstructive pulmonary disease: An emphasis on recently approved medications and products in the pipeline; Focus On Boceprevir: A new oral protease inhibitor for the treatment of chronic hepatitis C

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Formulary Digital Edition September 2011

Newsletter